Correction to: Curcumin in Advancing Treatment for Gynecological Cancers with Developed Drug- and Radiotherapy-Associated Resistance

other OA: closed public-domain-us
Full text JSON View on PubMed View at publisher
AI-generated summary by claude@2026-06, 2026-06-10

This paper corrects the author affiliation for Dr. Abolfazl Mehdizadehkashi to the Endometriosis Research Center, Iran University of Medical Sciences, Tehran, Iran.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-06, 2026-06-10 · read from full text

This document is a published correction to an earlier chapter titled “Curcumin in Advancing Treatment for Gynecological Cancers with Developed Drug- and Radiotherapy-Associated Resistance” in Reviews of Physiology, Biochemistry and Pharmacology. The authors report that the affiliation of the sixth author, Dr. Abolfazl Mehdizadehkashi, was incorrect and has been updated to the Endometriosis Research Center, Iran University of Medical Sciences, Tehran, Iran. No other study methods, results, or scientific conclusions are changed in the correction notice. This paper does not explicitly discuss endometriosis or adenomyosis; it was included in the corpus via a keyword match because an author’s corrected affiliation is the Endometriosis Research Center.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

The affiliation of the 6th author Dr. Abolfazl Mehdizadehkashi was incorrect. It has been corrected to Endometriosis Research Center, Iran University of Medical Sciences, Tehran, Iran.
Full text 1,403 characters · extracted from oa-doi-fallback · click to expand
You have full access to this open access chapter, Download chapter PDF Similar content being viewed by others 1 Correction to: Chapter “Curcumin in Advancing Treatment for Gynecological Cancers with Developed Drug- and Radiotherapy-Associated Resistance” in: A. A. Momtazi-Borojeni et al., Rev Physiol Biochem Pharmacol, DOI: 10.1007/112_2018_11 The affiliation of the 6th author Dr. Abolfazl Mehdizadehkashi was incorrect. It has been corrected to Endometriosis Research Center, Iran University of Medical Sciences, Tehran, Iran. Author information Authors and Affiliations Corresponding authors Editor information Editors and Affiliations Rights and permissions Copyright information © 2018 Springer Nature Switzerland AG About this chapter Cite this chapter Momtazi-Borojeni, A.A. et al. (2018). Correction to: Curcumin in Advancing Treatment for Gynecological Cancers with Developed Drug- and Radiotherapy-Associated Resistance. In: de Tombe, P., Gudermann, T., Jahn, R., Lill, R. (eds) Reviews of Physiology, Biochemistry and Pharmacology 176. Reviews of Physiology, Biochemistry and Pharmacology, vol 176. Springer, Cham. https://doi.org/10.1007/112_2018_14 Download citation DOI: https://doi.org/10.1007/112_2018_14 Published: Publisher Name: Springer, Cham Print ISBN: 978-3-030-14026-7 Online ISBN: 978-3-030-14027-4 eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosis

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-06-20T06:14:18.781669+00:00
pubmed
last seen: 2026-05-13T22:23:01.605684+00:00
unpaywall
last seen: 2026-06-13T06:42:57.164913+00:00
License: public-domain-us · commercial use OK · attribution required
Courtesy of the U.S. National Library of Medicine